Cleared Traditional

K233703 - Bone Anchor (NGS-BA-01)

K233703 is an FDA 510(k) clearance for Bone Anchor (NGS-BA-01), manufactured by ClearPoint Neuro, Inc.. The device is a Class 2 Neurology device with product code HAW cleared through the Traditional 510(k) pathway after a 161-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2024
Decision
161d
Days
Class 2
Risk

K233703 is an FDA 510(k) clearance for the Bone Anchor (NGS-BA-01). Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by ClearPoint Neuro, Inc. (Solana Beach, US). The FDA issued a Cleared decision on April 26, 2024 after a review of 161 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all ClearPoint Neuro, Inc. devices

FDA 510(k) Submission Details - K233703

510(k) Number K233703 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 17, 2023
Decision Date April 26, 2024
Days to Decision 161 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
13d slower than avg
Panel avg: 148d · This submission: 161d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HAW Device Classification - Class 2, Special Controls

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 242
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K233703.
Geniant Cranial (Navigated Neurosurgical Positioning Robot)
K241333 · KOH YOUNG TECHNOLOGY, Inc. · Jan 2025
FLASH EVD System (10-0002)
K242480 · 7D Surgical ULC · Dec 2024
Zeta Cranial Navigation System (ZNS131-US)
K242351 · Zeta Surgical, Inc. · Oct 2024
SmartFrame OR
K233141 · ClearPoint Neuro, Inc. · Jan 2024
ClearPoint Bone Screw Fiducials
K233144 · ClearPoint Neuro, Inc. · Jan 2024
ClearPointer Optical Navigation Wand
K233155 · ClearPoint Neuro, Inc. · Jan 2024